HC Wainwright & Co. Maintains Buy on InflaRx, Lowers Price Target to $6

HC Wainwright & Co. analyst Edward White maintains InflaRx (NASDAQ:IFRX) with a Buy and lowers the price target from $8 to $6.

HC Wainwright & Co. analyst Edward White maintains InflaRx (NASDAQ:IFRX) with a Buy and lowers the price target from $8 to $6.

Total
0
Shares
Related Posts
Read More

Martin Midstream Partners And 3 Other Penny Stocks Insiders Are Aggressively Buying

The Dow Jones jumped by more than 300 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

EEX